Moshe H. Rozenbaum - 25 Mar 2026 Form 4 Insider Report for Lifeward Ltd. (LFWD)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
13 Apr 2026, 18:43:29 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Almog Adar, as Attorney-in-Fact

Key filing fact

Moshe H. Rozenbaum filed Form 4 for Lifeward Ltd. (LFWD) on 13 Apr 2026.

Key facts

  • This page summarizes Moshe H. Rozenbaum's Form 4 filing for Lifeward Ltd. (LFWD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Apr 2026, 18:43.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002127856 Primary reporting owner

Rozenbaum Moshe H

Relationship
Director
Address
C/O LIFEWARD LTD., 2 CABOT RD., HUDSON
Signature
/s/ Almog Adar, as Attorney-in-Fact
Signature date
13 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFWD transaction

Ordinary Shares, no par value per share

Award

Transaction value
Shares
+11,485
Change %
Price
$0.000000*
Shares after
11,485
Date
25 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 11,485 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .